0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Asset Performance Management (APM) Market Size, Status and Forecast 2019-2025
Published Date: May 2019
|
Report Code: QYRE-Auto-18101
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Pharmaceutical Asset Performance Management APM Market Size Status and Forecast 2019 2025

Global Pharmaceutical Asset Performance Management (APM) Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-18101
Report
May 2019
107 Pages
QYResearch
Region: Global, United States, Europe, Central & South America, India, Southeast Asia, Japan, China, Germany,
Description
Table of Content
Tables & Figures


In 2018, the global Pharmaceutical Asset Performance Management (APM) market size was 92.5 million US$ and it is expected to reach 133 million US$ by the end of 2025, with a CAGR of 5.34% during 2019-2025.

This report focuses on the global Pharmaceutical Asset Performance Management (APM) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Asset Performance Management (APM) development in United States, Europe, China, Japan, Southeast Asia, India, Central & South America and Other Regions

The key players covered in this study

GE (U.S.)
Rockwell Software (U.S.)
AVEVA Group plc (U.K.)
Bentley Systems (U.S.)
AspenTech (U.S.)
Nexus Global (U.S.)
SAP (Germany)

Market segment by Type, the product can be split into

Asset Integrity Management
Asset Reliability Management
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Other Regions


1 Report Overview 1
1.1 Study Scope 1
1.2 Key Market Segments 1
1.3 Players Covered 2
1.4 Market Analysis by Type 3
1.4.1 Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type (2014-2025) 3
1.4.2 Asset Integrity Management 4
1.4.3 Asset Reliability Management 5
1.4.4 Other 6
1.6 Study Objectives 6
1.7 Years Considered 7
2 Global Growth Trends 8
2.1 Global Pharmaceutical Asset Performance Management (APM) Market Size 8
2.2 Pharmaceutical Asset Performance Management (APM) Growth Trends by Regions 9
2.2.1 Pharmaceutical Asset Performance Management (APM) Market Size by Regions (2019-2025) 9
2.2.2 Pharmaceutical Asset Performance Management (APM) Market Share by Regions (2014-2019) 10
2.3 Industry Trends 12
2.3.1 Market Top Trends 12
2.3.2 Market Drivers 13
3 Market Share by Key Players 15
3.1 Pharmaceutical Asset Performance Management (APM) Market Size by Players 15
3.1.1 Global Pharmaceutical Asset Performance Management (APM) Revenue by Players (2014-2019) 15
3.1.2 Global Pharmaceutical Asset Performance Management (APM) Revenue Market Share by Players (2014-2019) 16
3.1.3 Global Pharmaceutical Asset Performance Management (APM) Market Concentration Ratio (CR5) 17
3.2 Pharmaceutical Asset Performance Management (APM) Key Players Head office and Area Served 18
3.3 Key Players Pharmaceutical Asset Performance Management (APM) Product/Solution/Service 18
3.4 Mergers & Acquisitions, Expansion Plans 19
4 Breakdown Data by Type 21
5 United States 23
5.1 United States Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 23
5.2 Pharmaceutical Asset Performance Management (APM) Key Players in United States 23
5.3 United States Pharmaceutical Asset Performance Management (APM) Market Size by Type 24
6 Europe 26
6.1 Europe Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 26
6.2 Pharmaceutical Asset Performance Management (APM) Key Players in Europe 26
6.3 Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type 27
7 China 29
7.1 China Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 29
7.2 Pharmaceutical Asset Performance Management (APM) Key Players in China 29
7.3 China Pharmaceutical Asset Performance Management (APM) Market Size by Type 30
8 Japan 32
8.1 Japan Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 32
8.2 Pharmaceutical Asset Performance Management (APM) Key Players in Japan 32
8.3 Japan Pharmaceutical Asset Performance Management (APM) Market Size by Type 33
9 Southeast Asia 35
9.1 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 35
9.2 Pharmaceutical Asset Performance Management (APM) Key Players in Southeast Asia 35
9.3 Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type 36
10 India 38
10.1 India Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 38
10.2 Pharmaceutical Asset Performance Management (APM) Key Players in India 38
10.3 India Pharmaceutical Asset Performance Management (APM) Market Size by Type 39
11 Central & South America 41
11.1 Central & South America Pharmaceutical Asset Performance Management (APM) Market (2014-2019) 41
11.2 Pharmaceutical Asset Performance Management (APM) Key Players in Central & South America 41
11.3 Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Type 42
12 Key Players Profiles 44
12.1 GE (U.S.) 44
12.1.1 GE (U.S.) Company Details 44
12.1.2 GE (U.S.) Description and Business Overview 44
12.1.3 GE (U.S.) Pharmaceutical Asset Performance Management (APM) Introduction 45
12.1.4 GE (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 46
12.2 Rockwell Software (U.S.) 47
12.2.1 Rockwell Software (U.S.) Company Details 47
12.2.2 Rockwell Software (U.S.) Description and Business Overview 48
12.2.3 Rockwell Software (U.S.) Pharmaceutical Asset Performance Management (APM) Introduction 49
12.2.4 Rockwell Software (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 49
12.3 AVEVA Group plc (U.K.) 50
12.3.1 AVEVA Group plc (U.K.) Company Details 50
12.3.2 AVEVA Group plc (U.K.) Description and Business Overview 51
12.3.3 AVEVA Group plc (U.K.) Pharmaceutical Asset Performance Management (APM) Introduction 52
12.3.4 AVEVA Group plc (U.K.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 53
12.4 Bentley Systems (U.S.) 54
12.4.1 Bentley Systems (U.S.) Company Details 54
12.4.2 Bentley Systems (U.S.) Description and Business Overview 55
12.4.3 Bentley Systems (U.S.) Pharmaceutical Asset Performance Management (APM) Introduction 55
12.4.4 Bentley Systems (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 57
12.5 AspenTech (U.S.) 58
12.5.1 AspenTech (U.S.) Company Details 58
12.5.2 AspenTech (U.S.) Description and Business Overview 59
12.5.3 AspenTech (U.S.) Pharmaceutical Asset Performance Management (APM) Introduction 60
12.5.4 AspenTech (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 61
12.6 Nexus Global (U.S.) 62
12.6.1 Nexus Global (U.S.) Company Details 62
12.6.2 Nexus Global (U.S.) Description and Business Overview 62
12.6.3 Nexus Global (U.S.) Pharmaceutical Asset Performance Management (APM) Introduction 63
12.6.4 Nexus Global (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 64
12.7 SAP (Germany) 65
12.7.1 SAP (Germany) Company Details 65
12.7.2 SAP (Germany) Description and Business Overview 65
12.7.3 SAP (Germany) Pharmaceutical Asset Performance Management (APM) Introduction 66
12.7.4 SAP (Germany) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 67
13 Market Forecast 2019-2025 69
13.1 Market Size Forecast by Regions 69
13.2 United States 71
13.3 Europe 72
13.4 China 73
13.5 Japan 74
13.6 Southeast Asia 75
13.7 India 76
13.8 Central & South America 77
13.9 Market Size Forecast by Product (2019-2025) 77
14 Analyst's Viewpoints/Conclusions 79
15 Appendix 81
15.1 Research Methodology 81
15.1.1 Methodology/Research Approach 81
15.1.2 Data Source 88
15.2 Disclaimer 90
15.3 Author Details 92


Table Pharmaceutical Asset Performance Management (APM) Key Market Segments 1
Table Pharmaceutical Asset Performance Management (APM) Key Players Covered in 2018 2
Table Global Pharmaceutical Asset Performance Management (APM) Market Size Growth Rate by Type (2014-2025) (Million US$) 3
Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Type in 2018 4
Figure Asset Integrity Management Market Growth Rate (2014-2019) 5
Figure Asset Reliability Management Market Growth Rate (2014-2019) 5
Figure Pharmaceutical Asset Performance Management (APM) Report Years Considered 7
Figure Global Pharmaceutical Asset Performance Management (APM) Market Size and Growth Rate 2014-2025 (Million US$) 9
Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Regions 2019-2025 (Million US$) 9
Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Regions 2014-2019 (Million US$) 10
Table Global Pharmaceutical Asset Performance Management (APM) Market Share by Regions 2014-2019 10
Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Regions 2014-2019 11
Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Regions 2018 12
Table Market Top Trends 12
Table Market Drivers 13
Table Global Pharmaceutical Asset Performance Management (APM) Revenue by Players (2014-2019) (Million US$) 15
Table Global Pharmaceutical Asset Performance Management (APM) Market Share by Players (2014-2019) 16
Figure Global Pharmaceutical Asset Performance Management (APM) Market Share by Players in 2018 17
Table Global Pharmaceutical Asset Performance Management (APM) Manufacturers Market Concentration Ratio (CR5) 17
Table Key Players Head office and Area Served 18
Table Key Players Pharmaceutical Asset Performance Management (APM) Product/Solution/Service 19
Table Mergers & Acquisitions, Expansion Plans 19
Table Global Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 21
Table Global Pharmaceutical Asset Performance Management (APM) Market Size Share by Type (2014-2019) 21
Figure Global Pharmaceutical Asset Performance Management (APM) Market Size Market Share by Type (2014-2019) 22
Figure United States Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 23
Table United States Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 23
Table United States Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 24
Table United States Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 24
Table United States Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 25
Figure Europe Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 26
Table Europe Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 26
Table Europe Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 27
Table Europe Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 27
Table Europe Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 28
Figure China Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 29
Table China Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 29
Table China Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 30
Table China Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 30
Table China Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 31
Figure Japan Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 32
Table Japan Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 32
Table Japan Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 33
Table Japan Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 33
Table Japan Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 34
Figure Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 35
Table Southeast Asia Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 35
Table Southeast Asia Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 36
Table Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 36
Table Southeast Asia Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 37
Figure India Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 38
Table India Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 38
Table India Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 39
Table India Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 39
Table India Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 40
Figure Central & South America Pharmaceutical Asset Performance Management (APM) Market Size 2014-2019 (Million US$) 41
Table Central & South America Key Players Pharmaceutical Asset Performance Management (APM) Revenue (2018-2019) (Million US$) 41
Table Central & South America Key Players Pharmaceutical Asset Performance Management (APM) Market Share (2018-2019) 42
Table Central & South America Pharmaceutical Asset Performance Management (APM) Market Size by Type (2014-2019) (Million US$) 42
Table Central & South America Pharmaceutical Asset Performance Management (APM) Market Share by Type (2014-2019) 43
Table GE (U.S.) Pharmaceutical Asset Performance Management (APM) Product 45
Table GE (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 46
Figure GE (U.S.) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 47
Table Rockwell Software (U.S.) Pharmaceutical Asset Performance Management (APM) Product 49
Table Rockwell Software (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 49
Figure Rockwell Software (U.S.) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 50
Table AVEVA Group plc (U.K.) Description and Business Overview 51
Table AVEVA Group plc (U.K.) Pharmaceutical Asset Performance Management (APM) Product 52
Table AVEVA Group plc (U.K.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 53
Figure AVEVA Group plc (U.K.) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 53
Table Bentley Systems (U.S.) Description and Business Overview 55
Table Bentley Systems (U.S.) Pharmaceutical Asset Performance Management (APM) Product 55
Table Bentley Systems (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 57
Figure Bentley Systems (U.S.) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 58
Table AspenTech (U.S.) Description and Business Overview 59
Table AspenTech (U.S.) Pharmaceutical Asset Performance Management (APM) Product 60
Table AspenTech (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 61
Figure AspenTech (U.S.) Revenue Growth Rate in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) 61
Table Nexus Global (U.S.) Pharmaceutical Asset Performance Management (APM) Product 63
Table Nexus Global (U.S.) Revenue in Pharmaceutical Asset Performance Management (APM) Business (2014-2019) (Million US$) 64
Figure Nexus Global (U.S.)

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$2900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$4350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$5800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global Ciprofloxacin Hydrochloride CAS 93107 08 5 Market Insights Forecast to 2025
Global and United States Ciprofloxacin Hydrochloride (CAS 93107-08-5) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-0H777
Sun Jan 23 09:22:53 UTC 2022

Add to Cart

Global PCR Reagent Market Insights and Forecast to 2028
Global PCR Reagent Market Insights and Forecast to 2028

Market Analysis and Insights Global PCR Reagent MarketDue to the COVID19 pandemic the global PCR Reagent market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-28A9097
Wed Jan 19 00:00:00 UTC 2022

Add to Cart

Global Small Molecule Cancer Drug Market Insights and Forecast to 2028
Global Small Molecule Cancer Drug Market Insights and Forecast to 2028

Market Analysis and Insights Global Small Molecule Cancer Drug MarketDue to the COVID19 pandemic the global Small Molecule Cancer Drug market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-2V9651
Wed Jan 19 00:00:00 UTC 2022

Add to Cart

Global Chimeric Antibody Market Insights and Forecast to 2028
Global Chimeric Antibody Market Insights and Forecast to 2028

Because it reduces the murine component it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.Market Analysis and Insights Global Chimeric Antibody MarketThe global Chimeric Antibody market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis IgG accounting for of the Chimeric Antibody global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-14S9314
Wed Jan 19 00:00:00 UTC 2022

Add to Cart